Atyr Pharma
  • Pangu
  • Contact
  • Clinical Trials
  • Patients
Skip to content
  • Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Advisors
    • Contact
  • Our Science
    • tRNA SYNTHETASE BIOLOGY
    • Intellectual Property
    • Publications, Posters and Presentations
  • R&D
    • Pipeline
    • Efzofitimod
    • Research Programs
    • Pangu
  • Patients
    • Clinical Trials
    • About Pulmonary Sarcoidosis
    • EFZO-FIT™
    • About SSc-ILD
    • EFZO-CONNECT™
    • Expanded Access Policy
  • Careers
    • Working at aTyr
    • Career Opportunities
  • Investors and Media
    • News Releases
    • SEC Filings
    • Stock Information
    • Events and Webcasts
    • Investor Alerts
    • Corporate Governance
    • Analyst Coverage
    • Media
© 2007 - 2025   aTyr Pharma.   Legal   Privacy Policy

Identification of Key Fibrotic Extracellular Targets for Alanyl- and Aspartyl-tRNA Synthetases

International Symposium of Aminoacyl-tRNA Synthetases, 2023

« Identification of Latent Transforming Growth Factor Beta Binding Protein 1 (LTBP1) as a Binding Partner of Aspartyl-tRNA Synthetase
Alanyl-tRNA synthetase fragment binds to FGFR4 and induces morphological changes and downstream signaling in liver cells with functional similarities to FGF2 »
© 2007 - 2025   aTyr Pharma.   Legal   Privacy Policy
By continuing to browse this site, you agree to our use of cookies.
MENU
  • Company
    • About Us
    • Leadership Team
    • Board of Directors
    • Advisors
    • Contact
  • Our Science
    • Extracellular tRNA Synthetase Biology
    • Intellectual Property
    • Publications, Posters and Presentations
  • R&D
    • Pipeline
    • Efzofitimod
    • Research Programs
    • Pangu
  • Patients
    • Clinical Trials
    • About Pulmonary Sarcoidosis
    • EFZO-FIT™
    • About SSc-ILD
    • EFZO-CONNECT™
    • Expanded Access Policy
  • Careers
    • Working at aTyr
    • Career Opportunities
  • Investors and Media
    • Corporate Governance
      • Board of Directors
      • Board Committees
    • News Releases
    • SEC Filings
    • Stock Information
    • Analyst Coverage
    • Investor Alerts
    • Events and Webcasts
    • Media
  • Privacy Policy